Is BPC 157 Legal in Australia? Scheduling, Prescriptions and the TGA

Is BPC 157 legal in Australia? The short answer

Three facts frame the question, all checked against TGA publications on 30 September 2026:

1. BPC-157 is in Schedule 4 of the Poisons Standard. Schedule 4 is the "prescription only medicine" schedule.
2. No BPC-157 product is on the Australian Register of Therapeutic Goods. There is no approved, registered BPC-157 medicine in Australia.
3. The TGA treats unapproved peptide products as a compliance priority. Through 2026 it has issued repeated warnings and taken enforcement action over peptides including BPC-157.

Laws change, and state and territory poisons legislation sits on top of the federal Poisons Standard. Check the current Poisons Standard on the Federal Register of Legislation and the TGA website before relying on anything here.

How BPC-157 became Schedule 4

Before 2024, BPC-157 was not captured by the Poisons Standard at all. At the Advisory Committee on Medicines Scheduling meeting in November 2023 (ACMS #43), a proposal was considered to create a new Schedule 4 entry for it. The TGA's interim decision noted the proposal was made in response to 48 referrals for importation of BPC-157 received since 1 July 2022, and that it aimed to align BPC-157 with other performance and image enhancing substances.

The final decision, published on 22 May 2024, confirmed the new Schedule 4 entry with an implementation date of 1 June 2024. The delegate noted there was no reason to delay: BPC-157 is an unapproved medicine and no registered products were affected.

BPC-157 prescription in Australia

Schedule 4 means a substance is available on prescription from an authorised prescriber. That does not create a pharmacy product. Because no BPC-157 medicine is on the ARTG, any lawful clinical supply would have to go through the TGA's pathways for unapproved goods, which carry their own conditions for doctors and pharmacists. In April 2026 the TGA published a notice setting out the responsibilities of those who import, compound and supply unapproved peptide products, a sign that it is watching this channel closely.

Healthy Male, the Australian men's health organisation, states that possessing BPC-157 without a valid prescription is illegal. Whether and how a specific practitioner can prescribe it is a question for that practitioner and, if needed, a lawyer.

Does Chemist Warehouse sell BPC-157?

Searches for BPC-157 Chemist Warehouse and BPC 157 Chemist Warehouse are some of the most common in this topic, and the answer follows from the two facts above. Pharmacies such as Chemist Warehouse sell registered or listed medicines. BPC-157 is neither, and as a Schedule 4 substance it could never be an off-the-shelf retail product. There is no BPC-157 product on the ARTG for any pharmacy chain to stock.

Be wary of websites and social accounts that borrow pharmacy names or wording in their listings. A "warehouse" in a domain name tells you nothing about who is supplying the product or what is in the vial.

What the TGA has said about peptides in 2026

Readers should know the TGA's stated position, because it is blunt. In an April 2026 safety advisory, the TGA said it had seen a sharp rise in the import, supply, compounding and advertising of unapproved peptide products, naming BPC-157, TB-500, GHK-Cu, retatrutide and CJC-1295 as examples, and stated that it is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia. In July 2026 it announced it was stepping up compliance action, and a separate TGA notice put unapproved peptide promoters and suppliers "on notice", listing warning letters, infringement notices, seizures, civil penalties and, in serious cases, criminal prosecution. On 4 August 2026, TGA officers and NSW Police executed search warrants at two premises linked to a social media influencer, seizing products that included the "Wolverine Stack" of BPC-157 and TB-500.

The TGA has also said, in its guidance on what counts as a therapeutic good, that phrases like "for research purposes only" on a label do not change the law when products are supplied for people to use. Its guidance states plainly that disclaimers about how a product should be used do not change the law.

Research-use-only supply and what it does not mean

Chainwell Peptide supplies BPC-157 to laboratories and researchers strictly for in vitro and laboratory research. That is the only use we sell it for, and we do not supply it for human or veterinary use, give dosing advice, or make therapeutic claims (see our research use only statement). Our position is simple: a research-use label describes what a product is for, it is not a licence to use it on yourself, and the TGA has said as much.

If your work involves BPC-157, the right approach is to confirm your own obligations first: your institution's compliance office, the current Poisons Standard, and your state or territory poisons legislation. For product-level quality, every Chainwell Peptide lot is tested by an independent laboratory for identity (mass spectrometry) and purity (HPLC), and the report can be checked on our certificate lookup by lot number.

BPC-157 in sport

Separately from TGA law, BPC-157 is on the WADA Prohibited List under S0, Non-Approved Substances, banned in and out of competition, and Sport Integrity Australia applies that list to Australian athletes. TB-500 is prohibited under S2. Our review of BPC-157 safety evidence covers what is and is not known about the compound itself, and our BPC-157 background guide covers its origin.

Related tissue repair compounds are grouped in our tissue repair research peptides range, and the TB-500 10 mg research vial is listed separately. This page is general information current at the time of writing, not legal advice, and all products are for research use only.

Frequently asked questions